Poietis launch new 4D bioprinting system
Poietis (Pressac, France), the first 4D bioprinting company, has announced the launch of its novel range of Next Generation Bio-printing (NGB) systems. The new system can cover all tissue engineering needs, from research to clinical batch production. Poietis (Pressac, France) has been investing in Next Generation Bio-printing (NGB) 4D bioprinting platforms over the last 4 years due to the potential it has in meeting development and production demands of human biological tissues. The new system will be used to supply Poietis' three key markets, which include in vitro tissue models as an alternative to animal experimentation in dermo-cosmetics, pharmaceutical research...
